Savv-e Revenue and Competitors

Crows Nest, AU

Location

N/A

Total Funding

Learning

Industry

Estimated Revenue & Valuation

  • Savv-e's estimated annual revenue is currently $6.3M per year.(i)
  • Savv-e's estimated revenue per employee is $132,000

Employee Data

  • Savv-e has 48 Employees.(i)

Savv-e's People

NameTitleEmail/Phone
1
Manager, Client SolutionsReveal Email/Phone
2
Production ManagerReveal Email/Phone
3
Sales & Marketing ConsultantReveal Email/Phone
4
UI DesignerReveal Email/Phone
5
Project Lead / Learning DesignerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.7M43-17%N/AN/A
#2
$175.6M760N/AN/AN/A
#3
$1.7M17N/AN/AN/A
#4
$2.4M21N/AN/AN/A
#5
$2.3M20N/AN/AN/A
#6
$2.4M21N/AN/AN/A
#7
$6.3M48N/AN/AN/A
#8
$1M10N/AN/AN/A
#9
$301M1303N/AN/AN/A
#10
$41M226N/AN/AN/A
Add Company

What Is Savv-e?

keywords:N/A

N/A

Total Funding

48

Number of Employees

$6.3M

Revenue (est)

N/A

Employee Growth %

N/A

Valuation

N/A

Accelerator

Savv-e News

2022-04-13 - Analyzing Neovasc (NASDAQ:NVCN) & enVVeno Medical ...

... Device Designation from the U.S. Food and Drug Administration, and is currently being evaluated in the SAVVE U.S. clinical trial.

2022-04-06 - enVVeno Medical Announces New U.S. VenoValve(R) Patent

The VenoValve is currently being evaluated in leading hospitals throughout the U.S. in the ongoing SAVVE U.S pivotal trial.

2022-03-22 - enVVeno Medical Reports Fourth Quarter and Year-End 2021 ...

Successfully completed 9 VenoValve surgeries and 16 sites currently activated in the Company's SAVVE U.S. pivotal trial for the VenoValve;...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$5.4M48-11%N/A
#2
$6.8M5249%N/A
#3
$11.9M5216%N/A
#4
$10.6M56-10%N/A
#5
$5.5M602%N/A